# Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation

> **NCT07443709** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Oriol Manuel** · enrollment: 75 (estimated)

## Conditions studied

- Zoster; Herpes

## Interventions

- **BIOLOGICAL:** Booster dose of the recombinant zoster vaccine (RZV, Shingrix®)

## Key facts

- **NCT ID:** NCT07443709
- **Lead sponsor:** Oriol Manuel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-12
- **Final completion:** 2027-04
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07443709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07443709, "Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07443709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*